These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
349 related articles for article (PubMed ID: 36830672)
21. Identification and verification of eight cancer-associated fibroblasts related genes as a prognostic signature for head and neck squamous cell carcinoma. Dong L; Sun Q; Song F; Song X; Lu C; Li Y; Song X Heliyon; 2023 Mar; 9(3):e14003. PubMed ID: 36938461 [TBL] [Abstract][Full Text] [Related]
22. A novel seven‑miRNA prognostic model to predict overall survival in head and neck squamous cell carcinoma patients. Lu L; Wu Y; Feng M; Xue X; Fan Y Mol Med Rep; 2019 Nov; 20(5):4340-4348. PubMed ID: 31545440 [TBL] [Abstract][Full Text] [Related]
23. Identification and validation of a prognostic signature of autophagy, apoptosis and pyroptosis-related genes for head and neck squamous cell carcinoma: to imply therapeutic choices of HPV negative patients. Nan Z; Dou Y; Chen A; Wang K; Sun J; Meng Z; Neckenig M; Ai D; Liu S; Dong Z; Ma C; Cheng Y; Qu X Front Immunol; 2022; 13():1100417. PubMed ID: 36703967 [TBL] [Abstract][Full Text] [Related]
24. Six Glycolysis-Related Genes as Prognostic Risk Markers Can Predict the Prognosis of Patients with Head and Neck Squamous Cell Carcinoma. Chen L; He X; Yi S; Liu G; Liu Y; Ling Y Biomed Res Int; 2021; 2021():8824195. PubMed ID: 33628816 [TBL] [Abstract][Full Text] [Related]
25. UBE2C promotes the progression of head and neck squamous cell carcinoma. Jin Z; Zhao X; Cui L; Xu X; Zhao Y; Younai F; Messadi D; Hu S Biochem Biophys Res Commun; 2020 Mar; 523(2):389-397. PubMed ID: 31870550 [TBL] [Abstract][Full Text] [Related]
26. High eukaryotic initiation factor 5A2 expression predicts poor prognosis and may participate in the SNHG16/miR-10b-5p/EIF5A2 regulatory axis in head and neck squamous cell carcinoma. Ye S; Wang D; Jin M; Du J; Chen X; Zhang H; Zhou C; Fang S; Liu K J Clin Lab Anal; 2023 Jan; 37(1):e24820. PubMed ID: 36550070 [TBL] [Abstract][Full Text] [Related]
27. Development and validation of a fourteen- innate immunity-related gene pairs signature for predicting prognosis head and neck squamous cell carcinoma. Zhang F; Liu Y; Yang Y; Yang K BMC Cancer; 2020 Oct; 20(1):1015. PubMed ID: 33081731 [TBL] [Abstract][Full Text] [Related]
28. Retinol-binding protein type 1 expression predicts poor prognosis in head and neck squamous cell carcinoma. Fu LL; Yan M; Yu X; Shao M; Gosau M; Friedrich RE; Vollkommer T; Smeets R; Feng HC; Xu L BMC Cancer; 2024 Oct; 24(1):1277. PubMed ID: 39407127 [TBL] [Abstract][Full Text] [Related]
29. HOTTIP Functions as a Key Candidate Biomarker in Head and Neck Squamous Cell Carcinoma by Integrated Bioinformatic Analysis. Yin X; Yang W; Xie J; Wei Z; Tang C; Song C; Wang Y; Cai Y; Xu W; Han W Biomed Res Int; 2019; 2019():5450617. PubMed ID: 31032351 [TBL] [Abstract][Full Text] [Related]
30. Identification of Potential Biomarkers and Survival Analysis for Head and Neck Squamous Cell Carcinoma Using Bioinformatics Strategy: A Study Based on TCGA and GEO Datasets. Shen Y; Liu J; Zhang L; Dong S; Zhang J; Liu Y; Zhou H; Dong W Biomed Res Int; 2019; 2019():7376034. PubMed ID: 31485443 [TBL] [Abstract][Full Text] [Related]
31. Prognostic role of DFNA5 in head and neck squamous cell carcinoma revealed by systematic expression analysis. Liu Z; Liu H; Dong Q; Li H; Zhang B; Liu Y; Zhong L; Tang H BMC Cancer; 2021 Aug; 21(1):951. PubMed ID: 34433433 [TBL] [Abstract][Full Text] [Related]
32. Identification of Novel Prognostic Biomarkers in Head and Neck Squamous Cell Carcinoma using Bioinformatics Analysis. Ding Y; Li M; Tayier T; Chen L; Feng S Comb Chem High Throughput Screen; 2021; 24(9):1351-1363. PubMed ID: 33109035 [TBL] [Abstract][Full Text] [Related]
33. Identification and analysis of genes associated with head and neck squamous cell carcinoma by integrated bioinformatics methods. Jin Y; Yang Y Mol Genet Genomic Med; 2019 Aug; 7(8):e857. PubMed ID: 31304688 [TBL] [Abstract][Full Text] [Related]
34. Wei Z; Shen Y; Zhou C; Cao Y; Deng H; Shen Z Bioengineered; 2022 May; 13(5):13784-13800. PubMed ID: 35712757 [TBL] [Abstract][Full Text] [Related]
35. FAM3 Family as Prognostic Factors for Head and Neck Squamous Cell Carcinoma. Liao C; Wang Q; An J; Wang H; Xiao L; Long Q; Zhao H; Liu J; Guan X Comb Chem High Throughput Screen; 2023; 26(3):539-558. PubMed ID: 35538834 [TBL] [Abstract][Full Text] [Related]
36. Identification of prognostic marker genes in head and neck squamous cell carcinoma: A study based on The Cancer Genome Atlas database and experimental validation. Zhong Q; Zhou L; Zhu D J Oral Pathol Med; 2021 Oct; 50(9):891-901. PubMed ID: 33880801 [TBL] [Abstract][Full Text] [Related]
37. DOCK8 Serves as a Prognostic Biomarker and Is Related to Immune Infiltration in Patients With HPV Positive Head and Neck Squamous Cell Carcinoma. Zhang Z; Bao Y; Zhou L; Ye Y; Fu W; Sun C Cancer Control; 2021; 28():10732748211011951. PubMed ID: 33910393 [TBL] [Abstract][Full Text] [Related]
38. HtrA3: a promising prognostic biomarker and therapeutic target for head and neck squamous cell carcinoma. Chen Y; Yang J; Jin H; Wen W; Xu Y; Zhang X; Wang Y PeerJ; 2023; 11():e16237. PubMed ID: 37842043 [TBL] [Abstract][Full Text] [Related]
39. A model of seven immune checkpoint-related genes predicting overall survival for head and neck squamous cell carcinoma. Song D; Tian J; Han X; Li X Eur Arch Otorhinolaryngol; 2021 Sep; 278(9):3467-3477. PubMed ID: 33449165 [TBL] [Abstract][Full Text] [Related]
40. E2F4 transcription factor is a prognostic biomarker related to immune infiltration of head and neck squamous cell carcinoma. Qi L; Ren Z; Li W Sci Rep; 2022 Jul; 12(1):12132. PubMed ID: 35840663 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]